razoxane has been researched along with Carcinoma, Epidermoid in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byfield, JE; Clamon, GH; Corder, MP; Herbst, KD; Leimert, JT; Platz, CE; Tewfik, HH | 1 |
| Belloni, C; Bortolozzi, G; Carinelli, S; D'Incalci, M; Maggioni, A; Mangioni, C; Morasca, L | 1 |
| Baker, SR; Bricker, LJ; Natale, RB; Wheeler, RH | 1 |
| Horton, JJ; Wells, RS | 1 |
| Horton, JJ; MacDonald, DM; Wells, RS | 1 |
| Blessing, JA; Conroy, JF; Hatch, K; Lewis, GC; Mangan, C; Wilbanks, G | 1 |
| Arsenau, JC; Blessing, J; Lewis, GC; Slavik, M | 1 |
| Bellet, RE; Catalano, RB; Creech, RH; Engstrom, PF; Paul, AR; Shah, MK | 1 |
| Hassenstein, E; Rhomberg, W | 1 |
| Peters, LJ | 2 |
| Hsu, BM; Kasperbauer, JL; Pittelkow, MR; Scott, RE; Wilke, MS; Wille, JJ | 1 |
| Blessing, JA; Bonomi, P; Yordan, E | 1 |
4 trial(s) available for razoxane and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Radiotherapy plus razoxane for advanced limited extent carcinoma of the lung.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Blood Cell Count; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Drug Administration Schedule; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Piperazines; Pneumonia; Radiation Injuries; Random Allocation; Razoxane | 1984 |
ICRF 159 plus radiation versus radiation therapy alone in cervical carcinoma. A double-blind study.
Topics: Carcinoma, Squamous Cell; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Neoplasm Staging; Piperazines; Placebos; Razoxane; Uterine Cervical Neoplasms | 1983 |
[Combined treatment of lung carcinoma. Report on a prospective randomized study with radiotherapy and ICRF 159 (1,2-(3,5-dioxopiperazines-lyl)propane) (author's transl)].
Topics: Adenocarcinoma; Adult; Aged; Bronchial Neoplasms; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Female; Hematologic Diseases; Humans; Male; Middle Aged; Piperazines; Radioisotope Teletherapy; Radiotherapy Dosage; Radiotherapy, High-Energy; Razoxane | 1977 |
Phase I trial of cisplatin and razoxane (ICRF-159) (NSC #119875) in advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Pilot Study.
Topics: Adult; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Female; Humans; Middle Aged; Piperazines; Razoxane; Uterine Cervical Neoplasms | 1988 |
9 other study(ies) available for razoxane and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Phase II trial of ICRF-187 in squamous cell carcinoma of the head and neck.
Topics: Aged; Carcinoma, Squamous Cell; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Leukopenia; Male; Middle Aged; Piperazines; Razoxane | 1984 |
Razoxane: a review of 6 years' therapy in psoriasis.
Topics: Adult; Arthritis; Bone Marrow Diseases; Carcinoma, Squamous Cell; Humans; Leg Ulcer; Neutropenia; Piperazines; Psoriasis; Razoxane; Skin Neoplasms; Time Factors | 1983 |
Epitheliomas in patients receiving razoxane therapy for psoriasis.
Topics: Adult; Carcinoma, Squamous Cell; Humans; Male; Piperazines; Psoriasis; Razoxane; Skin Neoplasms | 1983 |
ICRF-159 (razoxane) in patients with advanced squamous cell carcinoma of the uterine cervix. For the Gynecologic Oncology Group.
Topics: Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Leukopenia; Piperazines; Razoxane; Thrombocytopenia; Uterine Cervical Neoplasms | 1984 |
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Etoposide; Female; Humans; Maytansine; Neoplasm Recurrence, Local; Pelvic Neoplasms; Piperazines; Razoxane; Research Design; Triazines | 1982 |
Phase II trial of razoxane (ICRF-159) in patients with squamous cell carcinoma of the head and neck previously exposed to systemic chemotherapy.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Piperazines; Razoxane | 1982 |
Modification of the radiocurability of a syngeneic murine squamous carcinoma by its site of growth, by electron-affinic drugs, and by ICRF 159.
Topics: Animals; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Imidazoles; Metronidazole; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Oxygen; Radiation-Sensitizing Agents; Razoxane; Skin Neoplasms; Transplantation, Homologous | 1976 |
A study of the influence of various diagnostic and therapeutic procedures applied to a murine squamous carcinoma on its metastatic behaviour.
Topics: Animals; Biopsy; Carcinoma, Squamous Cell; Disease Models, Animal; Female; Humans; Immunization; Lymph Node Excision; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Razoxane; Transplantation, Isogeneic | 1975 |
Human squamous carcinoma cells express complex defects in the control of proliferation and differentiation.
Topics: Calcium; Carcinoma, Squamous Cell; Cell Differentiation; Cell Division; Culture Media; Cytological Techniques; Ethionine; Growth Substances; Humans; Isoleucine; Razoxane; Tumor Cells, Cultured | 1988 |